Regions Financial Corp Exact Sciences Corp Transaction History

Regions Financial Corp

  • $13.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 19, 2019
SELL
$89.51 - $118.04 $8,324 - $10,977
-93 Closed
0 $0
Q1 2019

Apr 19, 2019
BUY
$61.98 - $96.5 $5,764 - $8,974
93 New
93 $8,000
Q1 2018

Apr 18, 2018
SELL
$39.82 - $57.53 $4,738 - $6,846
-119 Closed
0 $0
Q4 2017

Jan 18, 2018
BUY
$46.49 - $60.51 $5,532 - $7,200
119
119 $6,000

Others Institutions Holding EXAS

# of Institutions
676
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email